Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study Group For 25 High-Risk Items In August, Law Reform In Sight

This article was originally published in PharmAsia News

Executive Summary

After the Japanese government decided to lift the ban on Internet generic drug sales, MHLW has decided to set up a study group in August to decide how to sell 25 drugs considered as high risk items, stated Pharmaceutical and Food Director Toshio Imabeppu in his first specialist paper since taking office.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC085041

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel